Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.

导出 LinkOut

翻译打印收藏纠错

第一作者： Flavia A,Duarte

第一单位： Oncology Department, Oncoclínicas do Brasil, Belo Horizonte, Brazil.

作者： Flavia A,Duarte ^[1] ; Carlos Gil,Ferreira ^[2] ; Rodrigo,Dienstmann ^[3] ; Bruno L,Ferrari ^[1] ; Matheus,Costa E Silva ^[3] ; Pedro,Nazareth A Junior ^[3] ; Paulo,Guilherme de O Salles ^[4] ; Paulo,Henrique C Diniz ^[1]

作者单位： Oncology Department, Oncoclínicas do Brasil, Belo Horizonte, Brazil. ^[1] Oncology Department, Oncoclínicas Institute, Rio de Janeiro, Brazil. ^[2] Precision Medicine and Big Data Department, Oncoclínicas Group, São Paulo, Brazil. ^[3] Pathology Department, Roberto Alvarenga Institute, Belo Horizonte, Brazil. ^[4]

关键词 Precision medicine drug access non-small cell lung cancer

DOI 10.1080/20016689.2022.2077905

PMID 36353186

发布时间 2022-11-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of market access & health policy

2022年10卷1期

2077905页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.

Journal of market access & health policy

相似文献

Journal of market access & health policy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.

Journal of market access & health policy

相似文献

Journal of market access & health policy

相关期刊

检索历史清除